F. Hindilerden Et Al. , "Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection," BALKAN MEDICAL JOURNAL , vol.38, no.2, pp.141-142, 2021
Hindilerden, F. Et Al. 2021. Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection. BALKAN MEDICAL JOURNAL , vol.38, no.2 , 141-142.
Hindilerden, F., Hindilerden, I. Y., & Kucukkaya, R. D., (2021). Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection. BALKAN MEDICAL JOURNAL , vol.38, no.2, 141-142.
Hindilerden, Fehmi, Ipek Yonal Hindilerden, And Reyhan Diz Kucukkaya. "Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection," BALKAN MEDICAL JOURNAL , vol.38, no.2, 141-142, 2021
Hindilerden, Fehmi Et Al. "Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection." BALKAN MEDICAL JOURNAL , vol.38, no.2, pp.141-142, 2021
Hindilerden, F. Hindilerden, I. Y. And Kucukkaya, R. D. (2021) . "Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection." BALKAN MEDICAL JOURNAL , vol.38, no.2, pp.141-142.
@article{article, author={Fehmi HİNDİLERDEN Et Al. }, title={Rapid progression after ibrutinib discontinuation in a patient with mantle cell lymphoma who has severe coronavirus disease 2019 infection}, journal={BALKAN MEDICAL JOURNAL}, year=2021, pages={141-142} }